Industries
Pharmaceuticals
From development-stage companies preparing for their first cGMP campaign to established manufacturers supplying commercial markets, we support pharmaceutical organizations across the full compliance lifecycle.
xFDA supports pharmaceutical manufacturers with cGMP quality systems, manufacturing compliance, process and cleaning validation, QC laboratory operations, data integrity, CAPA and remediation — led by former FDA investigators and senior industry specialists who have run these systems in production environments.
How we support this sector
Where engagements typically focus
- Quality systems built to 21 CFR Parts 210 and 211 and ICH Q9/Q10 expectations
- Solid dose, liquid, semi-solid and sterile manufacturing compliance
- Process, cleaning and analytical method validation programs
- QC laboratory operations, stability programs and OOS investigations
- Technology transfer between development, clinical and commercial sites
- Contract manufacturer selection, quality agreements and oversight
Most engagements begin with a focused assessment: what the current system requires, what regulators expect, and the shortest defensible path between the two.
When companies call us
Situations we are asked into
- A quality system built for clinical supply now has to support commercial manufacturing.
- Repeat deviations in the same process step are not being closed by the current CAPA program.
- A legacy validated process no longer matches how the operation actually runs.
- A contract manufacturer needs qualification, a quality agreement and real oversight.
- A site is preparing for a pre-approval inspection and wants an honest technical assessment.
Questions we are asked
Pharmaceuticals: common questions
Direct answers from the consultants who do this work.
- What does a pharmaceutical GMP consultant actually do?
- A GMP consultant evaluates the quality system against 21 CFR Parts 210 and 211 and ICH Q9/Q10 expectations, identifies where practice diverges from procedure, and then helps rebuild the specific elements that are failing — investigations, validation, laboratory controls, change control or supplier oversight. The useful work is technical and hands-on, not a written opinion.
- How long does cGMP quality system remediation usually take?
- A focused assessment typically takes two to four weeks. A remediation program that rewrites investigation and CAPA practice, retrains staff and demonstrates sustained effectiveness usually runs six to eighteen months, because effectiveness has to be shown with real batches and real investigations, not with revised SOPs alone.
- When should a pharmaceutical company revalidate a process?
- Revalidation is warranted when the process, equipment, materials, scale or site changes materially, when continued process verification data shows drift outside the established control strategy, or when the original validation rationale no longer describes the current operation. The trigger is the control strategy, not a calendar interval.
- What are the most common pharmaceutical data integrity findings?
- Shared logins, disabled or unreviewed audit trails, unofficial 'trial' injections, incomplete contemporaneous documentation and paper records reconciled after the fact. Almost all of them trace back to a laboratory workload or system design problem rather than intent.
- Do you support pre-approval inspection preparation?
- We support the technical readiness of the systems an inspection will examine — validation packages, investigations, laboratory data and manufacturing records. For inspection-specific readiness programs, mock inspections and Form FDA 483 response, our sister firm FDAinspections.com is the right resource.
- Can you work with a small development-stage company?
- Yes. Development-stage engagements are usually about building proportionate systems — enough documentation discipline and control to support clinical supply and later scale — rather than importing a commercial manufacturer's quality manual.
Technical guidance for this sector
- Process ValidationProcess validation for a drug product is a three-stage lifecycle: design the process and its control strategy, qualify commercial-scale performance, and then verify that the process stays in control for as long as it is used.
- Cleaning ValidationCleaning validation demonstrates that a documented cleaning procedure consistently reduces residues to scientifically justified limits on shared equipment.
- cGMP ConsultingcGMP consulting for a drug manufacturer means making 21 CFR Parts 210 and 211 operable in your facility — with procedures your staff can follow, records that reconstruct what happened and a quality unit with the authority to act.
- Technology TransferTechnology transfer succeeds or fails on what the receiving site is given: process understanding, not just a batch record.
- Quality SystemsA pharmaceutical quality system is the set of connected processes — documents, changes, deviations, CAPA, training, release, review — that keep product decisions defensible.
- Data IntegrityLaboratory data integrity is a question of whether every reported result can be reconstructed from complete, attributable, contemporaneous records.
- GMP Laboratory ComplianceA GMP quality control laboratory is judged on laboratory controls: qualified instruments, validated methods, controlled reference standards, complete records and investigations that reach a conclusion.
- Method ValidationMethod validation demonstrates that an analytical procedure is suitable for its intended purpose.
- IND SupportFor an IND, the section that most often holds up a program is CMC.
- NDA SupportBy NDA, the manufacturing story has to be complete: a justified control strategy, validated process, qualified methods and a site that can demonstrate all of it during a pre-approval inspection.
- ANDA SupportGeneric applications are decided as much on manufacturing quality and data credibility as on bioequivalence.
- BLA SupportFor a biologic, the process is a substantial part of the product.
- IND CMC SupportSponsors filing an IND usually need two things at once: CMC content for the application and a quality system capable of overseeing clinical manufacturing.
- NDA Manufacturing SupportThis is the site-side companion to an NDA filing: making sure the validated process, the control strategy and the records at the manufacturing site match what the application says, and that the people there can explain it during a pre-approval inspection..
Newsletter
Insights from Former FDA & Industry Experts
Practical perspectives on GMP, quality systems, validation, manufacturing and development — written by the consultants doing the work. No newsletter-only sales pitches.
Start a project
Tell us what you're working on.
Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.